News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-04-02-2014
Volume10
Issue 4

AmerisourceBergen Acquires Minority Interest in Profarma

Author(s):

AmerisourceBergen to establish a joint venture for specialty distribution with Profarma.

AmerisourceBergen

reported that it has reached a definitive agreement to acquire a minority stake in Profarma, a pharmaceutical wholesaler in Brazil. In addition, AmerisourceBergen and Profarma will establish a joint venture for specialty distribution and services. The company expects to invest a total of approximately $100 million, and the transaction is expected to close in the June quarter of 2014.

AmerisourceBergen will purchase up to a 19.9% minority stake by offering $22.50 per share for shares offered in a primary offering by Profarma. This distribution joint venture will include Profarma’s existing specialty businesses and an equity investment from AmerisourceBergen. As a result, each company will own a 50% stake in the joint venture.

Source:

AmerisourceBergen

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content